Jennifer L. Taubert - Feb 13, 2024 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Role
EVP, WWC. Innovative Medicine
Signature
/s/ Raavi K. Deol, as attorney-in-fact for Jennifer Taubert
Stock symbol
JNJ
Transactions as of
Feb 13, 2024
Transactions value $
-$105,128
Form type
4
Date filed
2/15/2024, 04:53 PM
Previous filing
Feb 14, 2024
Next filing
Feb 20, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JNJ Common Stock Options Exercise $0 +1.3K +0.84% $0.00 156K Feb 13, 2024 Direct F1
transaction JNJ Common Stock Tax liability -$105K -666 -0.43% $157.85 155K Feb 13, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JNJ Restricted Share Units Options Exercise $0 -1.3K -33.33% $0.00 2.6K Feb 13, 2024 Common Stock 1.3K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting.
F2 Shares withheld for payment of taxes upon vesting of Restricted Share Units.